Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James C Costello

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR InhibitionAndrew Goodspeed, Annie Jean, Dan Theodorescu, et al.
Current Opinion in Systems Biology|September 22, 2023
Modeling genetic heterogeneity of drug response and resistance in cancerTeemu D Laajala, Travis Gerke, Svitlana Tyekucheva, et al.
BMC Systems Biology|June 9, 2018
Simulating heterogeneous populations using Boolean modelsBrian C Ross, Mayla Boguslav, Holly Weeks, et al.
Frontiers in Pharmacology|April 10, 2025
Editorial: State-of-the-art hypothesis-driven systems pharmacology and artificial intelligence approaches to decipher disease complexityCristina Correia, Choong-Yong Ung, Hu Li, et al.
Molecular Cancer Research : MCR|August 8, 2015
Tumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsAndrew Goodspeed, Laura M Heiser, Joe W Gray, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
From protein-disease associations to disease informaticsMehmet M Dalkilic, James C Costello, Wyatt T Clark, et al.
Evolution; International Journal of Organic Evolution|August 30, 2008
"Reverse ecology" and the power of population genomicsYong Fuga Li, James C Costello, Alisha K Holloway, et al.
Endocrine-Related Cancer|August 21, 2025
Systems biology successes and areas for opportunity in prostate cancerMichael V Orman, Laura S Graham, Scott D Cramer, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 8, 2018
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell LinesTahlita C M Zuiverloon, Florus C de Jong, James C Costello, et al.
Frontiers in Pharmacology|May 16, 2024
ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancerMichael V Orman, Varsha Sreekanth, Teemu D Laajala, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Bladder Cancer (Amsterdam, Netherlands)|August 17, 2018
A Gene Expression Signature Predicts Bladder Cancer Cell Line Sensitivity to EGFR InhibitionAndrew Goodspeed, Annie Jean, Dan Theodorescu, et al.
Current Opinion in Systems Biology|September 22, 2023
Modeling genetic heterogeneity of drug response and resistance in cancerTeemu D Laajala, Travis Gerke, Svitlana Tyekucheva, et al.
BMC Systems Biology|June 9, 2018
Simulating heterogeneous populations using Boolean modelsBrian C Ross, Mayla Boguslav, Holly Weeks, et al.
Frontiers in Pharmacology|April 10, 2025
Editorial: State-of-the-art hypothesis-driven systems pharmacology and artificial intelligence approaches to decipher disease complexityCristina Correia, Choong-Yong Ung, Hu Li, et al.
Molecular Cancer Research : MCR|August 8, 2015
Tumor-Derived Cell Lines as Molecular Models of Cancer PharmacogenomicsAndrew Goodspeed, Laura M Heiser, Joe W Gray, et al.
Frontiers in Bioscience : a Journal and Virtual Library|May 30, 2008
From protein-disease associations to disease informaticsMehmet M Dalkilic, James C Costello, Wyatt T Clark, et al.
Evolution; International Journal of Organic Evolution|August 30, 2008
"Reverse ecology" and the power of population genomicsYong Fuga Li, James C Costello, Alisha K Holloway, et al.
Endocrine-Related Cancer|August 21, 2025
Systems biology successes and areas for opportunity in prostate cancerMichael V Orman, Laura S Graham, Scott D Cramer, et al.
Bladder Cancer (Amsterdam, Netherlands)|May 8, 2018
Systematic Review: Characteristics and Preclinical Uses of Bladder Cancer Cell LinesTahlita C M Zuiverloon, Florus C de Jong, James C Costello, et al.
Frontiers in Pharmacology|May 16, 2024
ProstaMine: a bioinformatics tool for identifying subtype-specific co-alterations associated with aggressiveness in prostate cancerMichael V Orman, Varsha Sreekanth, Teemu D Laajala, et al.
Pageof 10